Skip to main content

Search by Department


Additional NIH Doctors/Researchers

Meet Our Doctors



Portrait of David Henderson
David Henderson, MD

Deputy Director for Clinical Care
Associate Director for Hospital Epidemiology and Quality Improvement


Hospital Epidemiology


BA, Hanover College
MD, University of Chicago


Email: dhenderson@mail.cc.nih.gov
Phone: 301-496-3515

Portrait of David Henderson
David Henderson, MD

Deputy Director for Clinical Care
Associate Director for Hospital Epidemiology and Quality Improvement


Hospital Epidemiology


BA, Hanover College
MD, University of Chicago


Email: dhenderson@mail.cc.nih.gov
Phone: 301-496-3515


Dr. David Henderson's primary research interests are in the occupational risks for, and prevention of, transmission of bloodborne pathogens, such as hepatitis B, hepatitis C, and HIV, in the healthcare setting, as well as in the epidemiology and prevention of healthcare-associated transmission of multidrug resistant organisms


Dr. Henderson is deputy director for clinical care at the NIH Clinical Center. He came to NIH in 1979 as the Clinical Center's first hospital epidemiologist.

After earning his undergraduate degree from Hanover College, Hanover, Indiana, and his medical degree from the University of Chicago's Pritzker School of Medicine, Dr. Henderson completed an internship and residency in internal medicine and a two-year fellowship in infectious diseases at Harbor-UCLA (University of California at Los Angeles) Medical Center. Subsequently, he was appointed assistant professor of medicine at the UCLA School of Medicine.

An invited speaker internationally, Dr. Henderson also is a frequently invited consultant to the Centers for Disease Control and Prevention.

He has published more than 160 peer-reviewed journal articles as well as dozens of book chapters.

His membership in medical organizations focuses on those with involvement in infectious diseases and healthcare epidemiology. He is a member of the Rapid Communications Task Force of the Infectious Diseases Society of America and was selected as the initial Chair of the Society for Healthcare Epidemiology of America (SHEA) Research Committee; he was one of founders of the SHEA Research Network.

In 2009 he was named to the DHHS Secretary's Steering Committee for the Prevention of Healthcare Associated Infections. From 2005 to the present he has been the NIH ex officio representative to the DHHS Secretary’s Healthcare Infection Control Policy Advisory Committee (HICPAC). He is a fellow of the Infectious Diseases Society of America, a fellow of the American College of Physicians and a fellow of the SHEA. In 2017, Dr. Henderson was elected as the incoming Vice President of SHEA. He is currently SHEA President-Elect and will assume the Presidency of SHEA in 2020.

Books and Book Chapters

Palmore TN, Henderson DK. Controlling the Spread of Resistant Pathogens in the Intensive Care Unit. Chapter 89, in Mayers, D (ed) Antimicrobial Drug Resistance. Humana Press, Springer Publishing, New York, NY. 2015, in press.

Beekmann SE, Henderson DK. Laboratory Support for Bloodborne Pathogen Exposures. In Clinical Microbiology Procedures Handbook, Garcia, L. (Editor–in-Chief). American Society for Microbiology Press, Washington, DC. 2015, in press.

Beekmann SE, Henderson DK. Chapter 41, Vascular Infection. In Clinical Infectious Diseases, Schlossberg, D. (Ed). Cambridge University Press, Cambridge, UK. 2015, in press.

Palmore TN, Henderson DK. Nosocomial herpesvirus infections. Chapter 308, In, Bennett JE, Dolin R, and Blaser MJ (Eds): Principles and Practice of Infectious Diseases. 8th Edition Elsevier, Churchill, Livingstone New York, 2014. 3376-83

Beekmann SE, Henderson DK. Infections caused by percutaneous intravascular devices. Chapter 302. In, Bennett JE, Dolin R, and Blaser MJ (Eds): Principles and Practice of Infectious Diseases. 8th Edition Elsevier, Churchill, Livingstone New York, 2014. 3310-24.

Henderson DK. Human immunodeficiency virus in healthcare settings. Chapter 307, In, Bennett JE, Dolin R, and Blaser MJ (Eds): Principles and Practice of Infectious Diseases. 8th Edition Elsevier, Churchill, Livingstone New York, 2014. 3361-75.

Henderson DK. Preventing Transmission of Bloodborne Pathogens in the Healthcare Setting. Chapter 43. In Jarvis WR, (Ed): Bennett and Brachman's Nosocomial Infections. 6th Edition. Lippincott, Williams and Wilkins, Philadelphia, PA, 2014. 644-66.

Lee LM, Yessis, J, Kost RG, Henderson DK Managing clinical risk and measuring participants' perceptions of the clinical research process. Chapter 39. In Gallin JI and Ognibene FO, (Eds): Principles and Practices of Clinical Research. Third Edition. Elsevier, San Diego, CA, 2011. 573-587.

Palmore, TN, Henderson DK. Employee Health/Occupational Medicine, Biosafety, and Infection Control. Chapter 24, In, Lautenbach E, Woeltje K, and Malani P (Eds): Practical Healthcare Epidemiology. 3rd Edition, University of Chicago Press, Chicago, IL, 2010; 319-30.

Lee, LM, Henderson DK. Hospital preparedness for emerging and highly contagious infectious diseases. Chapter 16, In, Mandell GL, Bennett JE, and Dolin R, (Eds): Principles and Practice of Infectious Diseases. 7th Edition Elsevier Churchill, Livingstone New York, 2009; 221-31.

Henderson DK, Fishman NO. Prevention and Control of Healthcare-Associated Infections, Chapter 305. In, Goldman L, and Bennett JC, (Eds): Cecil Textbook of Medicine. 22nd Edition. Elsevier Publishing, NY, NY, 2006, 2124-32.

Beekmann SE, Henderson DK. Chapter 79: Nosocomial human immunodeficiency virus infection in health-care workers. In, Mayhall CG (Ed): Hospital Epidemiology and Infection Control, 3rd Edition. Lippincott, Williams and Wilkins, Baltimore, MD, 2004, 1361-79.

Henderson DK, Beekmann SE. Chapter 78: Nosocomial viral hepatitis in health-care workers. In, Mayhall CG (Ed): Hospital Epidemiology and Infection Control, 3rd Edition. Lippincott, Williams and Wilkins, Baltimore, MD, 2004, 1337-60.

Henderson DK, Gerberding JL. Occupational and nonoccupational exposure management. In Dolin R, Masur H, and Saag MS (Eds): AIDS Therapy, 2nd ed. Churchill Livingstone, Philadelphia PA, 2003.327-46.

Henderson DK. Chapter 5.02b. Preventing occupational infection with the human immunodeficiency virus in the healthcare environment. In Powderly WG and Cohen J (Eds): Infectious Diseases, 2nd ed. Mosby, London, England, UK 2003, 1217-22.

Journal Articles

Johnson RC, Deming, C, Conlan S, Zellmer CJ, Michelin AV, Lee-Lin S-Q, Thomas PJ, Park M, the NISC Comparative Sequencing Program, Weingarten RA, Less J, Dekker JP, Frank KM, Musser KA, McQuiston JR, Henderson DK, Lau AF, Palmore TN, Segre JA. Investigation of a cluster of Sphingomonas koreensis Infections. N Engl J Med. 2018;379(26):2529-39.

Weingarten RA, Johnson RC, Conlan S, Ramsburg A, Dekker JP, Lau AF, Khil P, Odom RT, Deming C, Park M, Thomas PJ, NISC Comparative Sequencing Program, Henderson DK, Palmore TN, Segre JA, Frank KM. Genomic Analysis of Hospital Plumbing Reveals Diverse Reservoir of Bacterial Plasmids Conferring Carbapenem Resistance. MBio. 2018 Feb 6;9(1). pii: e02011-17. doi: 10.1128/mBio.02011-17.

Decker BK, Lau AF, Dekker JP, Spalding CD, Sinai N, Conlan S, Henderson DK, Segre JA, Frank KM, Palmore TN. Healthcare personnel intestinal colonization with multidrug-resistant organisms. Clin Microbiol Infect. 2017 May 12. pii: S1198-743X(17)30270-7. doi: 10.1016/j.cmi.2017.05.010

Chen M, Conlan S, Lau AF, Dekker JP, Deming C, NISC Comparative Sequencing Program, Henderson DK, Frank K, Palmore T, Segre, JA. Whole genome sequencing overrules a suspected case of carbapenem-resistant Enterobacter cloacae transmission. J Clin Microbiol 2017; 55(9): 2868-2870.

Vetter P, Dayer J-A, Schibler M, Allegranzi B, Brown D, Calmy A, Christie D, Eremin S, Hagon O, Henderson DK, Iten A, Kelley E, Marais F, Ndoye B, Pugin J, Robert-Nicoud H, Sterk E, Tapper M, Siegrist C-A, Kaiser L, Pittet D. The 2014-2015 Ebola outbreak in West Africa: Hands On. Antimicrob Resist Infect Control 2016. (5):1-17. DOI 10.1186/s13756-016-0112-9.

Hughes H, Henderson DK. Post-exposure prophylaxis after Hepatitis C occupational exposure in the interferon-free era. Curr Opin Infect Dis 2016, 29(4): 373-80.

Hughes H, Conlan S, Lau A, Dekker J, Michelin A, Youn J-H, Henderson DK, Frank KM, Segre JA, Palmore TN. Detection and whole genome sequencing of carbapenemase-producing Aeromonas hydrophila isolated from routine perirectal surveillance culture. J Clin Microbiol 2016. 54(4), 1167-70.

Palmore TN, Henderson DK. Intensifying the Focus on the Contribution of the Inanimate Environment to Health Care-Associated Infections. Ann Intern Med 2015. 163(8):642-3. 2015 Oct 20;163(8):642-3. doi: 10.7326/M15-1798. Epub 2015 Aug 11.

Palmore TN, Barrett, K. Davey RT, Henderson DK. Challenges in managing patients who have suspected or confirmed Ebola Virus infection at the National Institutes of Health. Infect Control Hosp Epidemiol.. Infect Control Hosp Epidemiol. 2015, available on CJO2015. doi:10.1017/ice.2015.60.

Conlan S, Thomas PJ, Deming C, Park M, Lau AF, Dekker JP, Snitkin ES, Clark TA, Luong K, Song, Tsai Y-C, Boitano M, Gupta I, Brooks SY, Schmidt B, Alice C. AC, Thomas JW, Bouffard GG, Blakesley RW, NISC Comparative Sequencing Program, Mullikin JC, Korlach J, Henderson DK, Frank KM*, Palmore TN*, Segre JA. Single molecule sequencing to track plasmid diversity of hospital-associated carbapenemase-producing Enterobacteriaceae. Sci Trans Med 2014 Sci Transl Med. 6(254), p. 254ra126 (1-12).

Kost RG, Lee L, Yessis J, Henderson DK, Wesley R, Coller BS. Assessing participant-centered outcomes to improve clinical research. N Engl J Med. 2013; 369(23): 2179-81.

Palmore TN, Henderson DK. Carbapenem-resistant Enterobacteriaceae: a call for cultural change. Ann Intern Med. 2014; 160(8):567-9.

Palmore TN, Henderson DK. Managing transmission of carbapenem-resistant Enterobacteriaceae in healthcare settings: A view from the trenches. Clin Infect Dis 2013 57(11): 1593-1599.

Kuhar DT, Henderson DK, Struble KA, Panlilio AL, Heneine W, Thomas V, Cheever LW, Gomaa A. Updated U.S. Public Health Service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis. Infect Control Hosp Epidemiol. 2013; 34(9): 875-92 (electronically published August 6, 2013).

Snitkin ES, Zelazny AM, Thomas PJ, Stock F, National Institutes of Health Intramural Sequencing Center Comparative Sequencing Program, Henderson DK, Palmore TN, Segre JA. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole genome sequencing. Science Translat Med 2012; 4(148)ra116 (1-9).

Henderson DK. Management of needlestick injuries: A houseofficer who sustains a needle stick during a code. JAMA 2012;307(1): 75-84.

Henderson DK. Use of adherence monitors as part of a team approach to control clonal spread of multidrug-resistant Acinetobacter baumannii in a research hospital. Infect Control Hosp Epidemiol. 2011; 32(12): 1166-72.

Turkel S, Henderson DK. Current strategies for managing providers infected with bloodborne pathogens. Infect Control Hosp Epidemiol. 2011; 32(5): 428-434.

Palmore TN, Michelin A, Bordner M, Odom R, Stock F, Fedorko D, Murray PR, Henderson DK, Palmore TN. Critical knowledge gaps in the epidemiology and pathophysiology of healthcare-associated infections. Infect Control Hosp Epidemiol. 2010; 31(S1): S4-6.

Henderson DK. Opportunists and opportunities: The 2010 SHEA Lecture. Infect Control Hosp Epidemiol. 2010; 31(S1): S66-69.

Henderson DK, Bonten M, Fishman NO, Gordon S, Harbarth S, Harris AD, Lautenbach E, Palmore TN, Perencevich EN, Perl TM, Platt R, Saint S, Samore M, MD, Sherertz R, Weber DJ, Weinstein RA, Deloney V, Sinaii N. Charting the course for the future of science in healthcare epidemiology: Results of a survey of the membership of The Society of Healthcare Epidemiology of America. Infect Control Hosp Epidemiol. Infect Control Hosp Epidemiol. 2010; 31(7): 669-75.

Lautenbach E, Saint S, Henderson DK, Harris AD. Initial response of healthcare institutions to emergence of H1N1 influenza: Experiences, obstacles, and perceived future needs. Clin Infect Dis. 2010; 50(4): 523-7.

Henderson DK, Grady C, Palmore TN, Weber D, Sepkowitz K, Dembry L, Lundstrom T, Fishman NO. Position Paper: Management of healthcare workers who are infected with HBV, HCV and HIV. Infect Control Hosp Epidemiol. 2010; 31(3): 204-32.

Palmore TN, Bonten M, Fishman N, Gordon S, Harbarth S, MD, Harris A, Lautenbach E, Perencevich E, Perl T, Platt R, Saint S, Samore M, Sheretz R, Weinstein RA, Henderson DK. White Paper: Enhancing patient safety by reducing healthcare-associated infection: the role of discovery and dissemination. Infect Control Hosp Epidemiol. 2010; 31(2):118-23.

Palmore TN, Vandersluis JP, Morris J, Michelin A, Ruprecht L, Schmitt JM, Henderson DK. A successful mandatory influenza vaccination campaign using an innovative electronic tracking system. Infect Control Hosp Epidemiol. 2009; 30(12):1137-42.

Palmore TN, Stock F, White M, Bordner MA, Michelin A, Bennett JE, Murray PR, Henderson DK. A cluster of nosocomial Legionnaire's disease linked to a contaminated hospital decorative water fountain. Infect Control Hosp Epidemiol. 2009; 30(8):764-8.

Henderson DK. Malanoski MP, Corapi G, Passamani E, Notobartolo C, Gillette C, Hawes P, Lee LM. The Bethesda Hospitals' Emergency Preparedness Partnership: A model for trans-institutional collaboration of emergency responses. Disaster Med Pub Hlth Prepared. 2009; 3(3):168-73.

Henderson DK. Managing occupational risks for hepatitis C transmission in the healthcare setting. Clin Microbiol Rev 2003;16(3):546-68.

Weinstein RA, Henderson DK. A double-edged sword and a golden opportunity for healthcare epidemiology. Infect Control Hosp Epidemiol. 2009; 30(1):1-3.

Lee LM, Henderson DK. Tolerability of Postexposure Antiretroviral Prophylaxis for Occupational Exposures to HIV, Drug Safety 2001: 24(8); 587-97.

Henderson DK. Postexposure chemoprophylaxis for occupational exposures to the Human Immunodeficiency Virus. JAMA 1999; 281(10):931-6.

Henderson DK. Postexposure antiretroviral chemoprophylaxis: embracing risk for safety’s sake. N Engl J Med 1997;337(21):1542-3.

Lee L, Anderson V, Piringer P, Boone J. Henderson DK. An epidemiologic approach to quality improvement, quality assurance and clinical research. Infect Control Hosp Epidemiol 1992;13:545-52.

Gerberding JL, Henderson DK. Managing occupational exposures to bloodborne pathogens: Hepatitis B virus, hepatitis C virus and human immunodeficiency virus. Clinical Infect Dis 1992;14:1179-85.

Fahey BJ, Koziol DE, Banks SM, Henderson DK. Frequency of nonparenteral occupational exposures to blood and body fluids before and after universal precautions training. Amer J Med 1991;90:145-53.

Henderson DK, Saah AJ, Zak BJ, et al. Risk of nosocomial infection with human T-cell lymphotropic virus-III (HTLV-III) in a large cohort of intensively exposed health care workers. Ann Intern Med 1986;104:644-7.

Henderson DK, Bennett JE, Huber M. Long-lasting, specific immunologic unresponsiveness associated with cryptococcosis. J Clin Invest 1982;69:1185-90.


  • Selected to receive the Alvan R. Feinstein Award from the American College of Physicians for career contributions to clinical epidemiology, 2019
  • Alumni Achievement Award, Hanover College, 2018
  • Elected incoming Vice-President, Society for Healthcare Epidemiology of America, 2018
    (President-Elect in 2019, President in 2020)
  • Department of Health and Human Services Secretary's Distinguished Service Award, (from former HHS secretary Tommy Thompson)
  • Department of Health and Human Services Secretary's Distinguished Service Award, (from former HHS secretary Michael Leavitt)
  • Received the Service to America Award as "Federal Employees of the Year" with three colleagues for work in controlling spread of MDROs in the Clinical Center, 2013
  • NIH Director's Awards, 2012
  • Selected as SHEA Lecturer, 5th International Decennial Conference on Nosocomial Infections by the Society of Healthcare Epidemiology in America (SHEA), 2010
  • NIH Director's Awards, 2009
  • NIH Director's Awards, 2006
  • Named NIH Liaison to the DHHS Secretary's Healthcare Infection Control Policy Advisory Committee (HICPAC), 2005
  • NIH Director's Awards, 2001
  • NIH Director's Awards,1998
  • NIH Director's Awards, 1992
  • Public Health Service Special Recognition Award
  • CC Director's Award
  • Director's Merit Awards for Significant Achievement from the National Institute of Mental Health
  • Director's Merit Awards for Significant Achievement from the National Institute of Mental Health
  • Member of the DHHS Secretary's steering committee to develop an action plan for Adverse Drug Events

NOTE: PDF documents require the free Adobe Reader.

This page last updated on 03/14/2019

You are now leaving the NIH Clinical Center website.

This external link is provided for your convenience to offer additional information. The NIH Clinical Center is not responsible for the availability, content or accuracy of this external site.

The NIH Clinical Center does not endorse, authorize or guarantee the sponsors, information, products or services described or offered at this external site. You will be subject to the destination site’s privacy policy if you follow this link.

More information about the NIH Clinical Center Privacy and Disclaimer policy is available at http://www.cc.nih.gov/disclaimers.html